v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
($580 and $432 from related parties, respectively) $ 54,883 $ 66,833
Costs and operating expenses:    
Costs of revenue, excluding depreciation and amortization of intangible assets 26,919 31,574
Research and development 12,379 22,102
Sales and marketing 7,745 12,576
General and administrative 17,701 23,192
Depreciation and amortization expense 7,563 7,800
Total costs and operating expenses 72,307 97,244
Loss from operations (17,424) (30,411)
Interest income and other income (expense), net 313 2,688
Net gain on divestiture 7,027 10,713
Loss before expense from income taxes and loss from equity method investment (10,084) (17,010)
Income tax expense (217) (568)
Loss from equity method investment 0 (778)
Net loss (10,301) (18,356)
Net income attributable to non-controlling interest 585 348
Net loss attributable to American Well Corporation $ (10,886) $ (18,704)
Net loss per share attributable to common stockholders, basic $ (0.66) $ (1.19)
Net loss per share attributable to common stockholders, diluted $ (0.66) $ (1.19)
Weighted-average common shares outstanding, basic 16,589,671 15,672,373
Weighted-average common shares outstanding, diluted 16,589,671 15,672,373
Net loss $ (10,301) $ (18,356)
Other comprehensive income (loss), net of tax:    
Foreign currency translation 28 (343)
Comprehensive loss (10,273) (18,699)
Less: Comprehensive income attributable to non-controlling interest 585 348
Comprehensive loss attributable to American Well Corporation $ (10,858) $ (19,047)